SCHEMBL5599647

SCHEMBL5599647

NNC(=O)[C@@H]1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5599650 1.00
SCHEMBL4592313 1.00
SCHEMBL29288134 0.94 PRCP (0.44)
SCHEMBL19815952 0.94 PRCP (0.44)
SCHEMBL5970059 0.84 PRCP (0.44)
SCHEMBL5794043 0.82 PRCP (0.51)
SCHEMBL17375664 0.82 PRCP (0.51)
SCHEMBL17375666 0.82 PRCP (0.51)
SCHEMBL5371415 0.81 GLI1 (0.64)
SCHEMBL443064 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5459156-A Angiotensin converting enzyme inhibitors, hypotensive, atherosclerosis BAYER AKTIENGESELLSCHAFT (DE) 1995-10-17 US claimed
WO-2007009299-A1 OPTICALLY PURE N',N'-DI SUBSTITUTED -PROLYLHYDRAZINES AS WELL AS THE PREPARATION AND USE THEREOF CHENGDU INSTITUTE OF BIOLOGY, CHINESE ACADEMY OF SCIENCES (CN) 2007-01-25 WO disclosed
WO-1992001938-A1 DERIVATIZATION OF C-TERMINAL PROLINE CITY OF HOPE (US) 1992-02-06 WO disclosed